• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌少症作为不良结局的死亡率。

Mortality as an adverse outcome of sarcopenia.

机构信息

Education Department at Instituto de Geriatría, México DF.

出版信息

J Nutr Health Aging. 2013 Mar;17(3):259-62. doi: 10.1007/s12603-012-0434-0.

DOI:10.1007/s12603-012-0434-0
PMID:23459979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4764255/
Abstract

Sarcopenia has an important impact in elderly. Recently the European Working Group on Sarcopenia in Older People (EWGSOP) defined sarcopenia as the loss of muscle mass plus low muscle strength or low physical performance. Lack of clinical sounding outcomes (ie external validity), is one of the flaws of this algorithm. The aim of our study was to determine the association of sarcopenia and mortality in a group of Mexican elderly. A total of 345 elderly were recruited in Mexico City, and followed up for three years. The EWGSOP algorithm was integrated by: gait speed, grip strength and calf circumference. Other covariates were assessed in order to test the independent association of sarcopenia with mortality. Of the 345 subjects, 53.3% were women; with a mean age of 78.5 (SD 7) years. During the three year follow-up a total of 43 (12.4%) subjects died. Age, cognition, ADL, IADL, health self-perception, ischemic heart disease and sarcopenia were associated in the bivariate analysis with survival. Negative predictive value for sarcopenia regarding mortality was of 90%. Kaplan-Meier curves along with their respective log-rank test were significant for sarcopenia. The components of the final Cox-regression multivariate model were age, ischemic heart disease, ADL and sarcopenia. Adjusted HR for age was 3.24 (CI 95% 1.55-6.78 p 0.002), IHD 5.07 (CI 95% 1.89-13.59 p 0.001), health self-perception 5.07 (CI 95% 1.9-13.6 p 0.001), ADL 0.75 (CI 95% 0.56-0.99 p 0.048) and sarcopenia 2.39 (CI 95% 1.05-5.43 p 0.037).

摘要

肌少症对老年人有重要影响。最近,欧洲老年人肌少症工作组(EWGSOP)将肌少症定义为肌肉质量减少加上肌肉力量低下或身体机能低下。该算法的一个缺陷是缺乏临床相关结果(即外部有效性)。我们的研究目的是确定肌少症与墨西哥一组老年人死亡率之间的关系。在墨西哥城共招募了 345 名老年人,并进行了为期三年的随访。EWGSOP 算法通过:步态速度、握力和小腿围来整合。评估了其他协变量,以测试肌少症与死亡率的独立相关性。在 345 名受试者中,53.3%为女性;平均年龄为 78.5(SD 7)岁。在三年的随访期间,共有 43 名(12.4%)受试者死亡。年龄、认知、ADL、IADL、健康自我感知、缺血性心脏病和肌少症在单变量分析中与生存相关。肌少症对死亡率的阴性预测值为 90%。肌少症的 Kaplan-Meier 曲线及其各自的对数秩检验具有显著性。最终 Cox 回归多变量模型的组成部分是年龄、缺血性心脏病、ADL 和肌少症。年龄的调整后的 HR 为 3.24(95%CI 1.55-6.78 p 0.002),缺血性心脏病为 5.07(95%CI 1.89-13.59 p 0.001),健康自我感知为 5.07(95%CI 1.9-13.6 p 0.001),ADL 为 0.75(95%CI 0.56-0.99 p 0.048),肌少症为 2.39(95%CI 1.05-5.43 p 0.037)。

相似文献

1
Mortality as an adverse outcome of sarcopenia.肌少症作为不良结局的死亡率。
J Nutr Health Aging. 2013 Mar;17(3):259-62. doi: 10.1007/s12603-012-0434-0.
2
Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly.根据欧洲老年人肌肉减少症工作组(EWGSOP)定义的肌肉减少症与肌无力作为老年人死亡风险因素的比较
J Nutr Health Aging. 2014;18(8):751-6. doi: 10.1007/s12603-014-0540-2.
3
The Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study.肌少症的欧洲老年人肌少症工作组(EWGSOP)定义的预测价值:InCHIANTI研究结果
J Gerontol A Biol Sci Med Sci. 2016 Feb;71(2):259-64. doi: 10.1093/gerona/glv129. Epub 2015 Sep 2.
4
Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study.衰弱高龄老年人(≥80 岁)的肌少症与死亡风险:来自 ilSIRENTE 研究的结果。
Age Ageing. 2013 Mar;42(2):203-9. doi: 10.1093/ageing/afs194. Epub 2013 Jan 15.
5
Sarcopenia and mortality in older people living in a nursing home in Turkey.土耳其养老院老年人肌少症与死亡率的关系。
Geriatr Gerontol Int. 2017 Jul;17(7):1118-1124. doi: 10.1111/ggi.12840. Epub 2016 Jul 20.
6
Prevalence of sarcopenia and its components in community-dwelling outpatient older adults and their relation with functionality.社区门诊老年患者中肌肉减少症及其组成部分的患病率及其与功能的关系。
Aging Male. 2020 Dec;23(5):424-430. doi: 10.1080/13685538.2018.1511976. Epub 2018 Oct 5.
7
Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.根据老年肌少症欧洲工作组(EWGSOP)定义确定肌少症的切点。
Clin Nutr. 2016 Dec;35(6):1557-1563. doi: 10.1016/j.clnu.2016.02.002. Epub 2016 Feb 11.
8
Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria.根据老年人肌少症欧洲工作组(EWGSOP)标准的改编版本,智利社区居住老年人的肌少症患病率
J Frailty Aging. 2017;6(1):12-17. doi: 10.14283/jfa.2016.117.
9
Motor function is the primary driver of the associations of sarcopenia and physical frailty with adverse health outcomes in community-dwelling older adults.肌肉减少症和身体虚弱与社区居住的老年人不良健康结果的关联主要受运动功能的驱动。
PLoS One. 2021 Feb 2;16(2):e0245680. doi: 10.1371/journal.pone.0245680. eCollection 2021.
10
Sarcopenia according to the european working group on sarcopenia in older people (EWGSOP) versus Dynapenia as a risk factor for disability in the elderly.根据欧洲老年人肌肉减少症工作组 (EWGSOP)的定义,与 dynapenia 相比,肌肉减少症是老年人残疾的一个风险因素。
J Nutr Health Aging. 2014 May;18(5):547-53. doi: 10.1007/s12603-014-0465-9.

引用本文的文献

1
Arabic Adaptation and Validation of the SARC-F Questionnaire for Sarcopenia Screening in Elderly Populations: Exploration of Associated Factors.阿拉伯语版SARC-F问卷在老年人群肌肉减少症筛查中的改编与验证:相关因素探索
J Aging Res. 2025 Aug 8;2025:7405872. doi: 10.1155/jare/7405872. eCollection 2025.
2
Improved Survival in Malnourished COVID-19 Inpatients with Oral Nutrition Supplementation.口服营养补充改善营养不良的新冠住院患者的生存状况。
Nutrients. 2025 Jul 23;17(15):2401. doi: 10.3390/nu17152401.
3
Differing dietary patterns according to body composition.

本文引用的文献

1
Sarcopenia and mortality among older nursing home residents.老年人疗养院居民中的肌肉减少症与死亡率。
J Am Med Dir Assoc. 2012 Feb;13(2):121-6. doi: 10.1016/j.jamda.2011.07.004.
2
Association between sarcopenia and mortality in healthy older people.健康老年人中肌肉减少症与死亡率之间的关联。
Australas J Ageing. 2011 Jun;30(2):89-92. doi: 10.1111/j.1741-6612.2010.00448.x. Epub 2011 Apr 13.
3
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.
根据身体成分不同的饮食模式。
Front Nutr. 2025 Jul 22;12:1509620. doi: 10.3389/fnut.2025.1509620. eCollection 2025.
4
Exploring the Science of Shape: How Physical Activity, Sleep, and Stress Affect Body Composition.探索形状的科学:身体活动、睡眠和压力如何影响身体成分。
Healthcare (Basel). 2025 Apr 20;13(8):949. doi: 10.3390/healthcare13080949.
5
The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study.中国三阴性乳腺癌患者肌肉减少症与临床结局的相关性:一项回顾性研究。
Front Oncol. 2025 Feb 6;15:1402300. doi: 10.3389/fonc.2025.1402300. eCollection 2025.
6
Development of an artificial intelligence-based application for the diagnosis of sarcopenia: a retrospective cohort study using the health examination dataset.基于人工智能的肌肉减少症诊断应用程序的开发:一项使用健康检查数据集的回顾性队列研究
BMC Med Inform Decis Mak. 2025 Feb 5;25(1):61. doi: 10.1186/s12911-025-02900-4.
7
Integrating data-driven and knowledge-driven approaches to analyze clinical notes with structured data for sarcopenia detection.将数据驱动和知识驱动方法与结构化数据相结合,分析临床笔记以检测肌肉减少症。
Health Informatics J. 2024 Oct-Dec;30(4):14604582241300025. doi: 10.1177/14604582241300025.
8
The role of algae, fungi, and insect-derived proteins and bioactive peptides in preventive and clinical nutrition.藻类、真菌以及昆虫衍生蛋白和生物活性肽在预防和临床营养中的作用。
Front Nutr. 2024 Oct 10;11:1461621. doi: 10.3389/fnut.2024.1461621. eCollection 2024.
9
Calf circumference was negatively associated with all-cause mortality among the Chinese centenarians: a prospective study with a 5-year follow-up.小腿围与中国百岁老人的全因死亡率呈负相关:一项前瞻性研究随访 5 年。
Aging Clin Exp Res. 2024 Oct 5;36(1):199. doi: 10.1007/s40520-024-02850-3.
10
Sarcopenia is a predictor for Alzheimer's continuum and related clinical outcomes.肌少症是阿尔茨海默病连续体和相关临床结局的预测因子。
Sci Rep. 2024 Sep 10;14(1):21074. doi: 10.1038/s41598-024-62918-y.
肌肉减少症:老年人未被诊断的病症。当前共识定义:患病率、病因和后果。国际肌肉减少症工作组。
J Am Med Dir Assoc. 2011 May;12(4):249-56. doi: 10.1016/j.jamda.2011.01.003. Epub 2011 Mar 4.
4
Evolution of sarcopenia research.肌肉减少症研究的演变。
Appl Physiol Nutr Metab. 2010 Oct;35(5):707-12. doi: 10.1139/H10-067.
5
Hertfordshire sarcopenia study: design and methods.赫特福德郡肌少症研究:设计与方法。
BMC Geriatr. 2010 Jun 29;10:43. doi: 10.1186/1471-2318-10-43.
6
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.肌肉减少症:欧洲定义和诊断共识:老年人肌肉减少症欧洲工作组报告。
Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
7
The Mini-mental State Examination revisited: ceiling and floor effects after score adjustment for educational level in an aging Mexican population.简易智力状态检查再探:在一个老龄化的墨西哥人群中,根据教育水平对分数进行调整后的天花板和地板效应。
Int Psychogeriatr. 2010 Feb;22(1):72-81. doi: 10.1017/S1041610209990822. Epub 2009 Sep 7.
8
Epidemiology and consequences of sarcopenia.肌肉减少症的流行病学及后果
J Nutr Health Aging. 2009 Oct;13(8):708-12. doi: 10.1007/s12603-009-0201-z.
9
Sarcopenia and frailty: a clinician's controversial point of view.肌肉减少症与衰弱:临床医生颇具争议的观点。
Exp Gerontol. 2008 Jul;43(7):674-678. doi: 10.1016/j.exger.2008.03.007. Epub 2008 Mar 25.
10
Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women.比较两种衰弱指数对老年女性跌倒、残疾、骨折和死亡的预测情况。
Arch Intern Med. 2008 Feb 25;168(4):382-9. doi: 10.1001/archinternmed.2007.113.